TABLE 2.
Hypertension alone | Presence of hypertension and diabetes | ||
Cardiology (n = 866) | Cardiology (n = 425) | Endocrinology (n = 688) | |
BP (mmHg) | |||
SBP | 140.7 ± 16.7 | 142.8 ± 17.2 | 139.8 ± 16.8b |
DBP | 83.8 ± 12.1 | 82.0 ± 12.3 | 79.2 ± 10.4a,b |
Treated, n (%) | 746 (86.1) | 391 (92.0)a | 533 (77.5)a,b |
Monotherapy | 366 (42.3) | 172 (40.5) | 360 (52.3)b |
Combination therapy | 380 (43.9) | 219 (51.5)a | 173 (25.1)a,b |
Use of ACE inhibitors or AT1 blockers | 378 (43.6) | 242 (56.9)a | 321 (46.7)b |
Controlled, n (%) | |||
SBP/DBP <140/90 mmHg | 348 (40.2) | 163 (38.3) | 285 (41.4) |
SBP/DBP <130/80 mmHg | 130 (15.0) | 61 (14.4) | 119 (17.3) |
ACE, angiotensin-converting enzyme; AT1, angiotensin type 1 receptor; BP, blood pressure.
aP ≤ 0.05 versus patients with hypertension alone.
bP ≤ 0.05 versus patients recruited from cardiology.